From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
Top Cited Papers
- 1 May 2014
- journal article
- review article
- Published by American Psychological Association (APA) in Psychological Bulletin
- Vol. 140 (3) , 774-815
Abstract
Major life stressors, especially those involving interpersonal stress and social rejection, are among the strongest proximal risk factors for depression. In this review, we propose a biologically plausible, multilevel theory that describes neural, physiologic, molecular, and genomic mechanisms that link experiences of social-environmental stress with internal biological processes that drive depression pathogenesis. Central to this social signal transduction theory of depression is the hypothesis that experiences of social threat and adversity up-regulate components of the immune system involved in inflammation. The key mediators of this response, called proinflammatory cytokines, can in turn elicit profound changes in behavior, which include the initiation of depressive symptoms such as sad mood, anhedonia, fatigue, psychomotor retardation, and social-behavioral withdrawal. This highly conserved biological response to adversity is critical for survival during times of actual physical threat or injury. However, this response can also be activated by modern-day social, symbolic, or imagined threats, leading to an increasingly proinflammatory phenotype that may be a key phenomenon driving depression pathogenesis and recurrence, as well as the overlap of depression with several somatic conditions including asthma, rheumatoid arthritis, chronic pain, metabolic syndrome, cardiovascular disease, obesity, and neurodegeneration. Insights from this theory may thus shed light on several important questions including how depression develops, why it frequently recurs, why it is strongly predicted by early life stress, and why it often co-occurs with symptoms of anxiety and with certain physical disease conditions. This work may also suggest new opportunities for preventing and treating depression by targeting inflammation.Keywords
Funding Information
- National Institutes of Health (R01 CA140933, R01 AG034588, R01 AG026364, R01 CA160245, R01 CA119159, R01 HL095799, R01 DA032922, and P30 AG028748)
- Society in Science
- UCLA Clinical and Translational Science Institute (UL1 TR000124)
- Cousins Center for Psychoneuroimmunology
This publication has 98 references indexed in Scilit:
- Risky families: Family social environments and the mental and physical health of offspring.Psychological Bulletin, 2002
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remissionEuropean Archives of Psychiatry and Clinical Neuroscience, 1997
- Cytokine-to-brain communication: A review & analysis of alternative mechanismsLife Sciences, 1995
- Immunity and depression: Insomnia, Retardation, and reduction of natural killer cell activityJournal of Behavioral Medicine, 1994
- Suicide associated with alfa-interferon therapy for chronic viral hepatitisJournal of Hepatology, 1994
- An overview of glucocorticoid anti-inflammatory actionsEuropean Journal of Clinical Pharmacology, 1993
- Α Review on the Acute Phase Response in Major DepressionReviews in the Neurosciences, 1993
- Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications.Journal of Abnormal Psychology, 1991
- Stress and immunity: An integrated view of relationships between the brain and the immune systemLife Sciences, 1989